Update on the 2017-2018 Influenza Season for Clinicians

Image of Continuing Education Credits abbreviation. = Free Continuing Education

Date: Thursday, February 8, 2018
Time: 2:00-3:00 pm (Eastern Time)

Follow these steps to earn free continuing education.


Influenza-related hospitalization rates so far in the 2017–2018 season are exceeding milestones set during the 2014–2015 season—a high severity, H3N2-predominant season. During this COCA call, CDC flu experts will address clinical issues for influenza patients, including those with severe disease, and provide the latest updates on the 2017-2018 influenza season.

At the conclusion of the session, the participant will be able to accomplish the following:

  • Explain the current status of influenza activity in the United States.
  • Identify available influenza tests.
  • List complications associated with influenza.
  • Describe antiviral treatment recommendations for influenza patients.

Call Slides: View Nowpdf icon
Webinar: Watch Nowmedia icon

Alicia P. Budd, MPH
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Tim Uyeki MD, MPH, MPP
Chief Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

  • Webinar/Audio conference call on 2/8/2018: 2:00 – 3:00 PM ET
  • Web-on-demand training after 3:00 PM ET on 2/8/2018
  • Materials: PowerPoint slide set

FluView – A weekly influenza surveillance report

Information for Health Professionals

Antiviral Drugs: Information for Health Care Professionals

Clinical Description & Lab Diagnosis of Influenza

“WC2922” for attendees who participate in the live call (must be completed by March 8, 2018)
“WD2922” for attendees who participate in the online presentation (must be completed by March 8, 2020)

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians
  • Contact Information:coca@cdc.gov
  • Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
  • Method of Participation:You may participate in the educational activity by viewing the program information above.
  • Fees:COCA continuing education credits are free.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

Image of acpe logo.CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-18-117-L04-P and enduring 0387-0000-18-117-H04-P  course category.
This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Uyeki’s discussion of oseltamivir antiviral treatment. He will be discussing that CDC recommends oseltamivir antiviral treatment for patients of all ages, and for hospitalized influenza patients.

CDC did not accept commercial support for this continuing education activity.

Page last reviewed: February 13, 2018